Quinoxaline 1,4-di-N-oxides: a review of the importance of their structure in the development of drugs against infectious diseases and cancer
Review
-
- Overview
-
- Research
-
- Identity
-
- Additional Document Info
-
- View All
-
Overview
abstract
-
Quinoxaline 1,4-di-N-oxides (QdNO’s) are potent drugs used since the middle of the last century as food additives to improve animal growth; however, their use as antibacterial agents led to an interest in investigating their mechanism of action, discovering that this heterocycle can cause DNA damage. Consequently, many molecules with different applications have been developed, with most of the research focused on studying their action as antibiotics, antifungals, antiparasitics, antituberculous, and anticancer agents. This review aims to present a condensate of the leading QdNO’s derivatives, as well as a description of the biological activities finding the importance of the nature and type of substituents present in positions R2, R3, R6, and R7 when they are biologically evaluated. [Figure not available: see fulltext.] © 2021, The Author(s), under exclusive licence to Springer Science%2bBusiness Media, LLC, part of Springer Nature.
publication date
funding provided via
published in
Research
keywords
-
Biological activity; Cancer; Infectious disease; Quinoxaline 1,4-di-N-oxides; Structure–activity relationship 4,9 dioxides furo [3,4 b]quinoxaline derivative; amide; antimycobacterial agent; chloroquine; natural product; oxide; primaquine; quinoxaline 1,4 di n oxide derivative; tirapazamine; unclassified drug; anthelmintic activity; antibacterial activity; antifungal activity; antimalarial activity; antineoplastic activity; antiparasitic activity; biological activity; cytotoxicity; drug development; drug structure; human; IC50; infection; malignant neoplasm; minimum inhibitory concentration; nonhuman; Review; structure activity relation
Identity
Digital Object Identifier (DOI)
PubMed ID
Additional Document Info
start page
end page
volume
issue